DIFFERENT CHARACTERISTICS OF AMPA RECEPTOR AGONISTS ACTING AT AMPA RECEPTORS EXPRESSED IN XENOPUS OOCYTES

Citation
P. Wahl et al., DIFFERENT CHARACTERISTICS OF AMPA RECEPTOR AGONISTS ACTING AT AMPA RECEPTORS EXPRESSED IN XENOPUS OOCYTES, European journal of pharmacology, 308(2), 1996, pp. 211-218
Citations number
47
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
308
Issue
2
Year of publication
1996
Pages
211 - 218
Database
ISI
SICI code
0014-2999(1996)308:2<211:DCOARA>2.0.ZU;2-U
Abstract
A series of amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (A MPA) analogues were evaluated for activity at homo-oligomeric glutamat e(1)-flop (Glu(1)-flop) receptors expressed in Xenopus oocytes, using the two-electrode voltage clamp technique. Amino-3-(3-carboxy-5-methyl -4-isoxazolyl)propionic acid (ACPA) (EC(50), 2.4 mu M), a homologue of AMPA having a carboxyl group as the terminal acidic functionality, wa s five times more potent than AMPA (EC(50), 12 mu M) and 20 times more potent than kainate (EC(50), 46 mu M). 3-hydroxy-5-trifluoromethyl-4- isoxazolyl)propionic acid (Tri-F-AMPA), in which an electronegative tr ifluoromethyl group is substituted for the methyl group on the isoxazo le ring in the AMPA structure, was three times more potent than AMPA, whereas ,7-tetrahydroisoxazolo[5,4-c]pyridine-5-carboxylic acid (5-HPC A), a bicyclic analogue of AMPA with highly restricted conformational flexibility was 10 times less potent than AMPA. The limiting slope of log-log plots of Glu(1)-flop receptor currents versus low agonist conc entrations had a value of 1.7 for ACPA and kainate compared to 1.5 for Tri-F-AMPA and 1.3 for 5-HPCA and AMPA, The amplitude of responses ev oked by near saturating concentrations of the agonists varied more tha n 7-fold, The sequence of efficacy was ACPA = kainate > Tri-F-AMPA > A MPA > 5-HPCA. Moreover, when saturating concentrations of Tri-F-AMPA a nd kainate were co-applied, the response was significantly greater tha n when each of the agonists was applied separately. The potency of the antagonist 3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX) (estimated K-B, similar to 200 nM), to block currents mediated by Glu( 1)-flop receptors was similar for all of the agonists tested in this s tudy. These results indicate that relatively minor changes in the mole cular structure of AMPA are associated with marked effects on potency and efficacy, In particular, it is suggested that the acidity of the t erminal group plays a major role in determining the degree of receptor activation in the steady state.